Drug Profile
Anti-CD55 monoclonal antibody
Latest Information Update: 09 May 2003
Price :
$50
*
At a glance
- Originator University of Cambridge
- Class Monoclonal antibodies
- Mechanism of Action CD55 antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 09 May 2003 Discontinued for Diabetes mellitus in United Kingdom (unspecified route)
- 15 Apr 1997 No-Development-Reported for Diabetes mellitus in United Kingdom (Unknown route)
- 23 Mar 1995 Investigation in Diabetes mellitus in United Kingdom (Unknown route)